Literature DB >> 11895330

Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.

Elizabeth Daro1, Eric Butz, Jeffrey Smith, Mark Teepe, Charles R Maliszewski, Hilary J McKenna.   

Abstract

Flt3 ligand (FL) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are important growth factors for dendritic cells (DC). Substantial numbers of DC can be generated in vivo following the administration of either factor. We sought to extend our knowledge of the functional properties of these cells including their ability to prime naïve CD8(+) T cells. In addition, we compared the nature of the DC generated in vivo with the single cytokines to those generated with the combination of FL+polyethylene glycol-modified GM-CSF (pGM-CSF). Treatment with FL+pGM-CSF yielded greater numbers of both CD11b(low) and CD11b(high) DC than with either cytokine alone, and these DC were more efficient at antigen (Ag) capture. The FL+pGM-CSF-generated CD11b(low) DC lacked expression of CD8alpha. Following treatment with LPS in vivo, all DC subsets upregulated CD40, CD80, CD86, and MHC class II expression, but surprisingly Ag capture was not downregulated and some DC subsets retained expression of intracellular MHC class II vesicles. Thus, even after activation in vivo with LPS, DC retained Ag capture properties of immature DC, and Ag presentation/costimulation properties of mature DC. Though all DC subsets stimulated CD4(+) T cell proliferation equivalently, FL-generated DC were more efficient at priming Ag-specific CD8(+) cytolytic T cells than DC generated with either pGM-CSF alone or FL+pGM-CSF, and CD11b(high) DC were more efficient at priming CD8(+) T cells than CD11b(low) DC. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895330     DOI: 10.1006/cyto.2001.0995

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

1.  Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  Daniel H Doherty; Mary S Rosendahl; Darin J Smith; Jennifer M Hughes; Elizabeth A Chlipala; George N Cox
Journal:  Bioconjug Chem       Date:  2005 Sep-Oct       Impact factor: 4.774

2.  In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis.

Authors:  Martin Guimond; Aharon G Freud; Hsiaoyin C Mao; Jianhua Yu; Bradley W Blaser; Jeffrey W Leong; Jeffrey B Vandeusen; Adrienne Dorrance; Jianying Zhang; Crystal L Mackall; Michael A Caligiuri
Journal:  J Immunol       Date:  2010-02-08       Impact factor: 5.422

3.  Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis.

Authors:  Matthew N Meriggioli; Jian Rong Sheng; Liangcheng Li; Bellur S Prabhakar
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

4.  Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes.

Authors:  Narumon Chalermsarp; Miyuki Azuma
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

5.  Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice.

Authors:  A C Vasquez; M Feili-Hariri; R J Tan; P A Morel
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

6.  Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis.

Authors:  Jian Rong Sheng; Liang Cheng Li; Balaji B Ganesh; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Clin Immunol       Date:  2008-05-27       Impact factor: 3.969

7.  Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors.

Authors:  Michael A Curran; James P Allison
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

8.  Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis.

Authors:  Satheesh K Sainathan; Eyad M Hanna; Qingqing Gong; Kumar S Bishnupuri; Qizhi Luo; Marco Colonna; Frances V White; Ed Croze; Courtney Houchen; Shrikant Anant; Brian K Dieckgraefe
Journal:  Inflamm Bowel Dis       Date:  2008-01       Impact factor: 5.325

9.  Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.

Authors:  Yongzhen Zhai; Yan Zhou; Ximei Li; Guohe Feng
Journal:  Mol Med Rep       Date:  2015-03-04       Impact factor: 2.952

10.  The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections.

Authors:  Joost J Smit; Dennis M Lindell; Louis Boon; Mirjam Kool; Bart N Lambrecht; Nicholas W Lukacs
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.